摘要
目的探讨含左氧氟沙星化疗方案治疗复治涂阳肺结核的临床疗效。方法选取医院2017年12月至2018年12月收治的复治涂阳肺结核患者62例,按治疗方法的不同分为对照组和观察组,各31例。两组患者均采取3HRZE/6HRE化疗,观察组患者加用左氧氟沙星治疗。结果研究组总有效率优于对照组,不良反应发生率低于对照组(P<0.05)。结论含左氧氟沙星化疗方案治疗复治涂阳肺结核的临床疗效显著,可降低不良反应发生率。
Objective To investigate the clinical efficacy of levofloxacin-containing chemotherapy regimen in the treatment of retreated smear-positive pulmonary tuberculosis.Methods Totally 62 retreated smear-positive pulmonary tuberculosis patients from December 2017 to December 2018 in our hospital were selected and divided into control group and observation group according to different treatment methods,31 cases in each group.Both groups were treated with 3HRZE/6HRE chemotherapy,on this basis,the observation group was treated with levofloxacin.Results The total effective rate of the study group was better than that of the control group,and the incidence rate of adverse reactions was lower than that of the control group(P<0.05). Conclusion Levofloxacin-containing chemotherapy regimen is effective in treating retreated smear-positive pulmonary tuberculosis and can reduce the incidence of adverse reactions.
出处
《中国药业》
CAS
2018年第A02期18-19,共2页
China Pharmaceuticals
关键词
左氧氟沙星
复治涂阳肺结核
临床疗效
levofloxacin
retreatment of smear-positive pulmonary tuberculosis
clinical efficacy
